ANI Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- ANI Pharmaceuticals's estimated annual revenue is currently $113.7M per year.
- ANI Pharmaceuticals received $125.0M in venture funding in January 2018.
- ANI Pharmaceuticals's estimated revenue per employee is $281,400
- ANI Pharmaceuticals's total funding is $200M.
Employee Data
- ANI Pharmaceuticals has 404 Employees.
- ANI Pharmaceuticals grew their employee count by 28% last year.
ANI Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Sr. VP, Corporate Development and Strategy | Reveal Email/Phone |
2 | CEO Office | Reveal Email/Phone |
3 | SVP Generics | Reveal Email/Phone |
4 | SVP, General Counsel and Corporate Secretary | Reveal Email/Phone |
5 | VP, Corporate Controller | Reveal Email/Phone |
6 | VP, Human Resources | Reveal Email/Phone |
7 | VP, US Market Access | Reveal Email/Phone |
8 | VP, US Sales | Reveal Email/Phone |
9 | SVP, General Counsel and Corporate Secretary | Reveal Email/Phone |
10 | VP Product Development | Reveal Email/Phone |
ANI Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $13.9M | 69 | -13% | N/A | N/A |
#2 | $110.3M | 549 | -3% | N/A | N/A |
#3 | $14.1M | 70 | 1% | N/A | N/A |
#4 | $1051.4M | 5231 | -5% | N/A | N/A |
#5 | $55.9M | 278 | 22% | N/A | N/A |
#6 | $50.3M | 250 | N/A | N/A | N/A |
#7 | $2.2M | 22 | 214% | N/A | N/A |
#8 | $1.4M | 7 | -87% | N/A | N/A |
#9 | $68.1M | 339 | 17% | N/A | N/A |
#10 | $19.5M | 97 | 0% | N/A | N/A |
What Is ANI Pharmaceuticals?
ANI Pharmaceuticals is an integrated specialty pharmaceutical company focused on delivering value to our customers by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals. We focus on niche and high barrier to entry opportunities including controlled substances, anti-cancer (oncolytics), hormones and steroids, and complex formulations. Our two pharmaceutical manufacturing facilities located in Baudette, Minnesota are capable of producing oral solid dose products, as well as liquids and topicals, controlled substances, and potent products that must be manufactured in a fully-contained environment. Our objective is to create long term shareholder value by building a sustainable and growing base business in generic and mature brand pharmaceutical products while advancing an opportunity to re-commercialize Cortrophin gel and Cortrophin-Zinc.
keywords:Healthcare,Pharmaceuticals
$200M
Total Funding
404
Number of Employees
$113.7M
Revenue (est)
28%
Employee Growth %
N/A
Valuation
N/A
Accelerator
ANI Pharmaceuticals News
ANI Pharmaceuticals, Inc, a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in...
ANI Pharmaceuticals, Inc. is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing, and marketing high...
ANI Pharmaceuticals, Inc. is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing, and marketing...
ANI Pharmaceuticals Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2016-05-16 | $30.0M | Undisclosed | Citizens Bank | Article |
| 2018-01-02 | $125.0M | Undisclosed | Citizens Bank | Article |